Fibrous proliferation of the pre-papillary canal in proliferative diabetic retinopathy: Cloquet's canal as a scaffold for proliferative diabetic retinopathy

Graefe's Archive for Clinical and Experimental Ophthalmology

Volumn 243, Issue 3, 2005, Pages 204-209

  Yamakiri, Keita ^a   Yamashita, Takehiro ^a   Miyazaki, Miho ^b   Doi, Norihito ^a   Uemura, Akinori ^c   Sakamoto, Taiji ^a  

^a KAGOSHIMA UNIVERSITY   (Japan)

^b KYUSHU UNIVERSITY   (Japan)

^c Kagoshima City Hospital   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

TRIAMCINOLONE;

ADULT; AGE; AGED; ARTICLE; CILIARY DISK; CLINICAL ARTICLE; CLINICAL FEATURE; DIABETIC RETINOPATHY; FEMALE; HUMAN; HYALOID CANAL; MALE; MARTEGIANI AREA; OCULAR FIBROSIS; OPTIC DISK; PATHOLOGICAL ANATOMY; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; RETROSPECTIVE STUDY; VITRECTOMY;

ADULT; AGED; AGED, 80 AND OVER; DIABETIC RETINOPATHY; FEMALE; FIBROSIS; FUNDUS OCULI; GLUCOCORTICOIDS; HUMANS; INJECTIONS; MALE; MIDDLE AGED; OPTIC DISK; PROSPECTIVE STUDIES; RETROSPECTIVE STUDIES; TRIAMCINOLONE ACETONIDE; VITRECTOMY; VITREOUS BODY;

EID: 17144364325     PISSN: 0721832X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00417-004-1001-0     Document Type: Article

References (22)

1. Davis MD (1965) Vitreous contraction in proliferative diabetic retinopathy. Arch Ophthalmol 74:979-982
2. Enaida H, Sakamoto T, Ueno A et al (2003) Submacular deposition of triamcinolone acetonide after triamcinolone-assisted vitrectomy. Am J Ophthalmol 135:243-246 10.1016/S0002-9394(02)01917-7
3. Enaida H, Hata Y, Ueno A et al (2003) Possible benefits of triamcinolone-assisted pars plana vitrectomy for retinal diseases. Retina 23:764-770 10.1097/00006982-200312000-00003
4. Foos RY, Wheeler NC (1982) Vitreoretinal juncture. Synchysis senilis and posterior vitreous detachment. Ophthalmology 89:1502-1512 1:STN:280:BiyC2c3nsVA%3D
5. TW Gardner GW Blankenship 1994 Proliferative diabetic retinopathy: principles and techniques of surgical treatment In: SJ Ryan (Eds.) Retina Mosby St Louis 2436-2483
6. Henkind P (1978) Ocular neovascularization. The Krill memorial lecture. Am J Ophthalmol 85:287-301 1:STN:280:CSeC1cvmt1w%3D
7. Hirata C, Nakano K, Nakamura N et al (1997) Advanced glycation end products induce expression of vascular endothelial growth factor by retinal Muller cells. Biochem Biophys Res Commun 236:712-715 10.1006/ bbrc.1997.7036
8. Jalkh A, Takahashi M, Topilow HW et al (1982) Prognostic value of vitreous findings in diabetic retinopathy. Arch Ophthalmol 100:432-434 1:STN:280:Bi2C2MbmvVQ%3D
9. Kishi S, Shimizu K (1993) Clinical manifestations of posterior precortical vitreous pocket in proliferative diabetic retinopathy. Ophthalmology 100:225-229 1:STN:280:ByyC2szkslI%3D
10. Kroll P, Wiegand W, Schmidt J (1999) Vitreopapillary traction in proliferative diabetic vitreoretinopathy. Br J Ophthalmol 83:261-264 1:STN:280:DyaK1M3ptlelsQ%3D%3D
11. Milibak T (1997) Cellular infiltration of Cloquet's canal. Br J Ophthalmol 81:802 1:STN:280:DyaK1c%2FosV2itA%3D%3D
12. Peyman GA, Cheema R, Conway MD et al (2000) Triamcinolone acetonide as an aid to visualization of the vitreous and the posterior hyaloid durin pars plana vitrectomy. Retina 20:554-555 1:STN:280:DC%2BD3cvovVCkug%3D%3D
13. Sakamoto T, Fujiisawa K, Kinukawa N et al (2002) Re-worsening factor after successful vitrectomy for diabetic retinopathy: Optic disc fibrovascular proliferation and macular disease. Ophthalmologica 216:101-107 10.1159/000048307
14. Sakamoto T, Miyazaki M, Hisatomi T et al (2002) Triamcinolone-assisted pars plana vitrectomy improves the surgical procedures and decreases the post-operative blood-ocular barrier breakdown. Graefes Arch Clin Exp Ophthalmol 240:423-429 10.1007/s00417-002-0454-2
15. Sebag J (1987) Age-related changes in human vitreous structure. Graefes Arch Clin Exp Ophthalmol 225:89-93 1:STN:280:BiiB3Mbpt1M%3D
16. Sebag J (1992) Anatomy and pathology of the vitreo-retinal interface. Eye 6:541-552 1289128
17. Sebag J (1997) Classifying posterior vitreous detachment: A new way to look at the invisible. Br J Ophthalmol 81:521-522 1:STN:280:BiiB3Mbpt1M%3D
18. Sebag J (2002) Imaging vitreous. Eye 16:429-439 10.1038/sj.eye.6700201
19. Sebag J, Buckingham B, Charles MA et al (1992) Biochemical abnormalities in vitreous of humans with proliferative diabetic retinopathy. Arch Ophthalmol 110:1472-1476 1:STN:280:ByyD3sfit1U%3D
20. Sonoda KH, Ueno A, Enaida H et al (2003) Pars plana vitrectomy assisted by triamcinolone acetonide for refractory uveitis: A case series study. Br J Ophthalmol 87:1010-1014 10.1136/bjo.87.8.1010
21. Sonoda KH, Sakamoto T, Enaida H et al (2004) Residual vitreous cortex after surgical posterior vitreous separation visualized by intravitreous triamcinolone acetonide. Ophthalmology 111:226-230 10.1016/ j.ophtha.2003.05.034
22. Takahashi M, Trempe CL, Maguire K et al (1981) Vitreoretinal relationship in diabetic retinopathy. A biomicroscopic evaluation. Arch Ophthalmol 99:241-245 1:STN:280:Bi6C3szgtFw%3D